Maternal Cardiometabolic Risk Factors Tied to Higher BP in Offspring
By Lori Solomon HealthDay Reporter
WEDNESDAY, May 14, 2025 -- Maternal cardiometabolic risk factors are significantly associated with higher blood pressure (BP) in childhood for their offspring, according to a study published online May 8 in JAMA Network Open.
Zhongzheng Niu, Ph.D., from the University of Southern California in Los Angeles, and colleagues examined the association between maternal cardiometabolic risk factors during pregnancy and offspring BP. The analysis included 12,480 mother-offspring pairs participating in the Environmental Influences on Child Health Outcomes program.
The researchers found that offspring born to mothers with any cardiometabolic risk factors had higher systolic BP (4.88 percentile points) and higher diastolic BP (1.90 percentile points) at their first BP measurement, when adjusting for potential confounders, compared with their counterparts without any risk factors. There was a significant association with higher offspring BP for hypertensive disorders of pregnancy, alone or with either prepregnancy obesity or gestational diabetes. Among female offspring, these associations were generally more significant than for male offspring and among Black offspring versus offspring from other racial and ethnic groups. Among 6,015 offspring with two or more BP measures, maternal cardiometabolic risk factors were associated with an increased rate of BP change from age 2 to 18 years (systolic BP percentile, 0.5 per year; diastolic BP percentile, 0.7 per year).
"These findings suggest that protecting pregnant individuals from cardiometabolic risk factors may promote healthier blood pressure in the next generation," the authors write.
Two authors disclosed ties to pharmaceutical companies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension
MONDAY, July 21, 2025 -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved...
ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
FRIDAY, July 18, 2025 -- All individuals with hypertension should be screened for primary aldosteronism (PA), according to a clinical practice guideline issued by the Endocrine...
Delays in HTN Diagnosis Linked to Delays in Medication Prescribing
THURSDAY, July 17, 2025 -- Delays in diagnosis of hypertension are common and associated with delays in treatment initiation, according to a study published online July 14 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.